Personalized vaccine with chemotherapy for glioblastoma
Treatments studied
Part of Cancer clinical trials.
This trial tests a personalized cancer vaccine made from your own tumor, combined with standard chemotherapy and a drug that helps your immune system fight the cancer. It aims to see if this combination can improve outcomes for people with glioblastoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 71 years old.
- You have glioblastoma (a type of brain cancer) confirmed by a biopsy, and a tissue sample has been sent to the study company for testing.
- You are generally able to care for yourself (a doctor's score of 80% or higher).
- Your blood counts, liver, kidney, and other lab values are within certain healthy ranges.
- You must be willing to have a biopsy during treatment, and use effective birth control during and for 3 months after the study.
- You should not have had prior immunotherapy with PD-1/PD-L1 drugs, or steroid treatment in the last 6 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.
This trial tests a combination of a personalized cancer vaccine (made from your own tumor), chemotherapy, and an immunotherapy drug (like pembrolizumab) for people with triple-negative breast cancer that has spread or can't be removed and has stopped responding to standard treatment. The goal is to see if this combination can help shrink or control the cancer.
This trial tests a personalized vaccine made from your own tumor cells, given after standard treatment (surgery and chemo/radiation) for newly diagnosed glioblastoma. The vaccine aims to train your immune system to fight any remaining cancer cells.
This trial tests a personalized vaccine (made from your own cells) combined with a common chemotherapy drug, temozolomide, for people with newly diagnosed glioblastoma. The goal is to train your immune system to fight the tumor and hopefully slow its growth.
This trial tests an experimental 'vaccine' made from your own immune cells (dendritic cells). The vaccine is designed to train your immune system to attack the brain tumor. It is for people whose glioblastoma has returned or progressed after standard treatment.
This trial offers a personalized vaccine (DCVax-L) made from your own tumor cells to patients with glioblastoma (a type of brain cancer) who were not able to join a previous study. The vaccine aims to help your immune system fight the cancer.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.